Jim Simons A Tyr Pharma Inc Put Options Transaction History
Renaissance Technologies LLC
- $70.6 Billion
- Q2 2025
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
Others Institutions Holding LIFE
# of Institutions
117Shares Held
50.1MCall Options Held
642KPut Options Held
548K-
Federated Hermes, Inc. Pittsburgh, PA14.7MShares$27.3 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.66MShares$8.66 Million0.0% of portfolio
-
Octagon Capital Advisors LP New York, NY3.82MShares$7.11 Million2.7% of portfolio
-
Tikvah Management LLC Charlotte, NC2.46MShares$4.58 Million1.64% of portfolio
-
Geode Capital Management, LLC Boston, MA2.1MShares$3.9 Million0.0% of portfolio
About aTYR PHARMA INC
- Ticker LIFE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,625,000
- Market Cap $53.2M
- Description
- aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...